

The Adderall XR shortage continues in 2026. Get the latest update on availability, cost, and what you can do to find your medication.
The Adderall XR shortage is now in its fourth year. If you're one of the millions of Americans who depend on this medication for ADHD, you already know how stressful it is to wonder whether you'll be able to fill your prescription each month.
In this update, we'll cover what's happening with the Adderall XR shortage in 2026, why it's still going on, how much it costs, and what steps you can take right now.
Yes. As of early 2026, Adderall XR (amphetamine/dextroamphetamine extended-release) remains in an active shortage according to the FDA and the American Society of Health-System Pharmacists (ASHP). Multiple strengths of the generic extended-release capsules — particularly the 15 mg, 25 mg, and 30 mg — are on back order from several manufacturers, with estimated release dates pushed to late February 2026 and beyond.
While some doses (like 5 mg and 10 mg) may be more available, patients who take higher doses are having the hardest time. The shortage affects both brand-name Adderall XR and generic versions (amphetamine salt combo XR).
The shortage is driven by a combination of factors that we've covered in detail in our article on why Adderall XR is so hard to find. Here's a quick summary:
Cost is a real concern for many patients, especially during a shortage when you may need to fill your prescription at a different pharmacy or pay out of pocket.
Here's what you can expect:
For detailed tips on reducing your costs, see our guide on how to save money on Adderall XR.
While there's no brand-new Adderall XR formulation, there are some developments worth knowing about:
For a full rundown of alternatives, see our article on alternatives to Adderall XR.
Here are the most effective steps you can take right now:
For more detailed tips, see our full guide on how to find Adderall XR in stock near you.
The Adderall XR shortage is one of the longest-running drug shortages in recent memory, and it continues to affect patients in 2026. While there are reasons for cautious optimism — DEA quota increases, new generic options, and growing awareness of the problem — the reality on the ground is that many patients are still struggling.
Stay proactive. Use Medfinder to track availability, keep your prescriber informed, and explore your options. You shouldn't have to choose between your health and a broken supply chain.
You focus on staying healthy. We'll handle the rest.
Try Medfinder Concierge FreeMedfinder's mission is to ensure every patient gets access to the medications they need. We believe this begins with trustworthy information. Our core values guide everything we do, including the standards that shape the accuracy, transparency, and quality of our content. We’re committed to delivering information that’s evidence-based, regularly updated, and easy to understand. For more details on our editorial process, see here.